287 related articles for article (PubMed ID: 19739128)
21. Distinct subcellular expression patterns of neutral endopeptidase (CD10) in prostate cancer predict diverging clinical courses in surgically treated patients.
Fleischmann A; Schlomm T; Huland H; Köllermann J; Simon P; Mirlacher M; Salomon G; Chun FH; Steuber T; Simon R; Sauter G; Graefen M; Erbersdobler A
Clin Cancer Res; 2008 Dec; 14(23):7838-42. PubMed ID: 19047112
[TBL] [Abstract][Full Text] [Related]
22. Association of global levels of histone modifications with recurrence-free survival in stage IIB and III esophageal squamous cell carcinomas.
I H; Ko E; Kim Y; Cho EY; Han J; Park J; Kim K; Kim DH; Shim YM
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):566-73. PubMed ID: 20142251
[TBL] [Abstract][Full Text] [Related]
23. Prostatic chondroitin sulfate is increased in patients with metastatic disease but does not predict survival outcome.
Ricciardelli C; Sakko AJ; Stahl J; Tilley WD; Marshall VR; Horsfall DJ
Prostate; 2009 May; 69(7):761-9. PubMed ID: 19189303
[TBL] [Abstract][Full Text] [Related]
24. Predictive value of prostate-specific antigen expression in prostate cancer: a tissue microarray study.
Erbersdobler A; Isbarn H; Steiner I; Schlomm T; Chun F; Mirlacher M; Sauter G
Urology; 2009 Nov; 74(5):1169-73. PubMed ID: 19476978
[TBL] [Abstract][Full Text] [Related]
25. Heat shock proteins 27, 60 and 70 as prognostic markers of prostate cancer.
Glaessgen A; Jonmarker S; Lindberg A; Nilsson B; Lewensohn R; Ekman P; Valdman A; Egevad L
APMIS; 2008 Oct; 116(10):888-95. PubMed ID: 19132982
[TBL] [Abstract][Full Text] [Related]
26. H3K4 histone methylation in oral squamous cell carcinoma.
Mancuso M; Matassa DS; Conte M; Colella G; Rana G; Fucci L; Piscopo M
Acta Biochim Pol; 2009; 56(3):405-10. PubMed ID: 19753335
[TBL] [Abstract][Full Text] [Related]
27. Post-treatment circulating plasma BMP6 mRNA and H3K27 methylation levels discriminate metastatic prostate cancer from localized disease.
Deligezer U; Yaman F; Darendeliler E; Dizdar Y; Holdenrieder S; Kovancilar M; Dalay N
Clin Chim Acta; 2010 Oct; 411(19-20):1452-6. PubMed ID: 20573596
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical level of unsulfated chondroitin disaccharides in the cancer stroma is an independent predictor of prostate cancer relapse.
Sakko AJ; Butler MS; Byers S; Reinboth BJ; Stahl J; Kench JG; Horvath LG; Sutherland RL; Stricker PD; Henshall SM; Marshall VR; Tilley WD; Horsfall DJ; Ricciardelli C
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2488-97. PubMed ID: 18768520
[TBL] [Abstract][Full Text] [Related]
29. The importance of determining the aggressiveness of prostate cancer using serum and tissue molecular markers.
Kehinde EO; Maghrebi MA; Anim JT
Can J Urol; 2008 Apr; 15(2):3967-74. PubMed ID: 18405443
[TBL] [Abstract][Full Text] [Related]
30. Conformal radiotherapy for detectable PSA following radical prostatectomy: efficacy and predictive factors of recurrence.
Delongchamps NB; Zerbib M; Mejean A; Rouach Y; Debre B; Peyromaure M
Can J Urol; 2009 Oct; 16(5):4813-9. PubMed ID: 19796456
[TBL] [Abstract][Full Text] [Related]
31. The global histone modification pattern correlates with overall survival in metachronous liver metastasis of colorectal cancer.
Tamagawa H; Oshima T; Shiozawa M; Morinaga S; Nakamura Y; Yoshihara M; Sakuma Y; Kameda Y; Akaike M; Masuda M; Imada T; Miyagi Y
Oncol Rep; 2012 Mar; 27(3):637-42. PubMed ID: 22076537
[TBL] [Abstract][Full Text] [Related]
32. Predictive value of plasma hepatocyte growth factor/scatter factor levels in patients with clinically localized prostate cancer.
Gupta A; Karakiewicz PI; Roehrborn CG; Lotan Y; Zlotta AR; Shariat SF
Clin Cancer Res; 2008 Nov; 14(22):7385-90. PubMed ID: 19010854
[TBL] [Abstract][Full Text] [Related]
33. P110β Inhibition Reduces Histone H3K4 Di-Methylation in Prostate Cancer.
Pang J; Yang YW; Huang Y; Yang J; Zhang H; Chen R; Dong L; Huang Y; Wang D; Liu J; Li B
Prostate; 2017 Feb; 77(3):299-308. PubMed ID: 27800642
[TBL] [Abstract][Full Text] [Related]
34. JMJD3 is a histone H3K27 demethylase.
Xiang Y; Zhu Z; Han G; Lin H; Xu L; Chen CD
Cell Res; 2007 Oct; 17(10):850-7. PubMed ID: 17923864
[TBL] [Abstract][Full Text] [Related]
35. Global histone modification pattern predicts poor prognosis in organic hyperinsulinism.
Raffel A; Krausch M; Roushan K; Anlauf M; Henopp T; Hafner D; Lehwald N; Kröpil F; Schott M; Eisenberger CF; Knoefel WT; Stoecklein NH
Horm Metab Res; 2011 Nov; 43(12):858-64. PubMed ID: 22105476
[TBL] [Abstract][Full Text] [Related]
36. Histone methylation defines an epigenetic entity in penile squamous cell carcinoma.
Rogenhofer S; Miersch H; Göke F; Kahl P; Wieland WF; Hofstädter F; Kristiansen G; von Ruecker A; Müller SC; Ellinger J
J Urol; 2013 Mar; 189(3):1117-22. PubMed ID: 22999995
[TBL] [Abstract][Full Text] [Related]
37. Alterations of global histone H4K20 methylation during prostate carcinogenesis.
Behbahani TE; Kahl P; von der Gathen J; Heukamp LC; Baumann C; Gütgemann I; Walter B; Hofstädter F; Bastian PJ; von Ruecker A; Müller SC; Rogenhofer S; Ellinger J
BMC Urol; 2012 Mar; 12():5. PubMed ID: 22413846
[TBL] [Abstract][Full Text] [Related]
38. Dysregulation of Sirtuin 2 (SIRT2) and histone H3K18 acetylation pathways associates with adverse prostate cancer outcomes.
Damodaran S; Damaschke N; Gawdzik J; Yang B; Shi C; Allen GO; Huang W; Denu J; Jarrard D
BMC Cancer; 2017 Dec; 17(1):874. PubMed ID: 29262808
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of the leptin and leptin receptor expressions in prostate tissues.
Hoon Kim J; Lee SY; Myung SC; Kim YS; Kim TH; Kim MK
Asian J Androl; 2008 Nov; 10(6):923-8. PubMed ID: 18958356
[TBL] [Abstract][Full Text] [Related]
40. Global histone modification of histone H3 in colorectal cancer and its precursor lesions.
Nakazawa T; Kondo T; Ma D; Niu D; Mochizuki K; Kawasaki T; Yamane T; Iino H; Fujii H; Katoh R
Hum Pathol; 2012 Jun; 43(6):834-42. PubMed ID: 21917293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
